Le Lézard
Classified in: Health
Subjects: TRI, FDA

Esaote North America announces a new gold standard in Open MRI with the FDA approved Magnificotm Open MRI system.


FISHERS, Ind, Feb. 10, 2022 /PRNewswire/ -- Esaote North America, Inc. is proud to announce the FDA approval of the Magnificotm Open MRI, a new open whole-body MRI system now available for purchase in the USA. The Magnificotm Open, was designed with the user in mind through customer feedback to bridge the gap between traditional musculoskeletal imaging and whole-body imaging.

The Magnificotm Open is equipped with new advanced technologies that offer versatility in imaging across a wide range of clinical applications:

"The Magnificotm Open is designed for patient comfort", says Stephen Gibbs, Manager of MRI Sales & Marketing for Esaote North America. "With an open-gantry design it is ideal for imaging children, large and claustrophobic patients. The compact size is uniquely suited for hospitals, imaging centers, and in-office clinics."

"As MRI backlogs continue to rise, the demand for high-performance MRI is at an all-time high", says Robert Lewis, President and General Manager of Esaote North America. "Now is the right time to bring open whole-body MRI to the US market, to help ease these scheduling challenges, while freeing up time slots on overloaded systems to accommodate more patients at the point of care."

Drawing upon a 30-year legacy, Esaote continues to stay at the forefront, delivering cost-effective and eco-friendly diagnostic imaging solutions that meet the clinical and financial demands of customers worldwide.

About Esaote 

Esaote North America, as part of the international Esaote Group, continues to develop and distribute innovative medical imaging systems, with the support of one of the world's leading medical imaging companies. Esaote S.p.A. is a leader in medical device manufacturing in the areas of Ultrasound, Dedicated MRI, and Healthcare IT. Esaote's headquarters are in Genoa, Italy with an international presence in 100 countries.

Logo - https://mma.prnewswire.com/media/1421470/Esaote_North_America_Logo.jpg
Photo - https://mma.prnewswire.com/media/1743459/Esaote_MRI.jpg

SOURCE Esaote North America


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: